Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Mar 16, 2017, after the close
10-K filed Mar 17, 2017, 76 days after period end · 0001171843-17-001588
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $26.42M | $28.37M | $30.36M | $27.85M |
| Net Income | -$1.32M | -$17.14M | -$19.00K | -$756.00K |
| EPS Diluted | -$0.04 |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.51 |
| $0.00 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
